Overview

Rasburicase Treatment in Chronic Gouty Arthritis

Status:
Not yet recruiting
Trial end date:
2025-04-15
Target enrollment:
Participant gender:
Summary
The study will establish efficacy and safety of rasburicase in chronic gouty arthritis
Phase:
Phase 4
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Treatments:
Rasburicase